Resapp Health Share Price and Company Fundamentals
Last traded: Today at 4:34 AM
Raptor Metals Limited, an exploration company, acquires a portfolio of exploration properties in Canada and Australia. It explores for silver, copper, gold, zinc, nickel, and lead deposits. The company's flagship property is the 100% owned Chester Copper project, consist of 281 mineral claims covering an area of approximately 6,176 hectares located in northern New Brunswick within the Bathurst Mining Camp. The company was formerly known as Eastern Metals Limited and change is name to Raptor Metals Limited in January 2026. Raptor Metals Limited was incorporated in 2020 and is based in Perth, Australia.
Key Metrics
PE ratio
-
PB ratio
1.36
Dividend yield
0.00%
Beta
1.27
Market cap
$9.44M
Enterprise value
$8.20M
Company profile
| Industry / Sector | Other Precious Metals & Mining / Basic Materials |
|---|---|
| Website | https://raptormetals.com.au |
| Mailing address | 216 St Georges Terrace Level 8 London House Perth WA 6000 Australia |
| Phone / Fax | 61 8 9481 0389 / 61 8 9463 6103 |
Dividends
More: Resapp Health Dividend history, yield and payout ratio
Dividend yield
0.00%
Dividend amount
$-
Payout ratio
-
5Y Avg. yield
-%
Resapp Health paid $- dividend and the ex-dividend date was -.The dividend payout ratio is -. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.
Company Executives
As of Nov 2026, following are the company executives and directors listed on Resapp Health.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Brett Wallace L.L.B. | MD & Director | ||
| Ms. Amanda Jane Wilton-Heald B.Com, CA | Company Secretary | 48 |
Profitability and management effectiveness
Profit margin
0.00%
Operating margin
-77319.52%
Return on assets
-24.17%
Return on equity
-86.99%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Resapp Health is 9.44M and its enterprise value is 8.20M. The enterprise value to revenue ratio of RAP is 3219.75. The enterprise value to EBITDA ratio of RAP is -4.22.
The RAP's stocks Beta value is 1.27 making it 27% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Resapp Health (RAP)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Resapp Health (ASX:RAP) Frequently Asked Questions
1. What is Resapp Health's Stock Symbol?
Resapp Health trades on ASX under the ticker symbol "RAP".
2. What is Resapp Health's stock price today?
One share of RAP stock can currently be purchased for approximately $0.015.
3. How can I contact Resapp Health?
Resapp Health's mailing address is 216 St Georges Terrace Level 8 London House Perth WA 6000 Australia. The company can be reached via phone at 61 8 9481 0389.
4. What is Resapp Health's official website?
The official website of Resapp Health is https://raptormetals.com.au.